November 01, 2025
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreNovember 01, 2025
The simulators market size is projected to expand from USD 14.72 billion in 2026 to USD 25.53 billion by 2034,...
Read MoreDecember 22, 2025
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreNovember 13, 2025
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreNovember 01, 2025
Based on market forecasts, the global viral vector gene therapy market, projected at USD 13.14 billion in 2024, is expected to reach USD 38.39 billion by 2034, growing at a CAGR of 11.23% over the forecast period. The viral vector gene therapy market is growing due to rising demand for targeted treatments for genetic and rare diseases. Advancements...
November 01, 2025
Around the world, the sex-based drug development market is driven by the rising approaches to sex-based differences, like pharmacokinetic, pharmacodynamic, and hormonal characteristics. Whereas, North America dominated the global market, with a growing number of research activities and an increasing focus on personalized approaches in drug developm...
November 01, 2025
The mechanobiology-centered therapy market is expanding due to growing mechanosensitive treatment approaches as well as rising mechanobiology research. North America led the market due to the presence of well-developed industries....
November 01, 2025
Projections indicate that, the global rare disease treatment market will increase from USD 195.21 billion in 2024 to USD 587.08 billion by 2034, experiencing a CAGR of 11.64% over the next 10 years.The rising prevalence of rare diseases and growing research and development activities foster market growth. North America dominated the global market o...
November 01, 2025
The temperature-sensitive drug market is expanding due to increasing vaccination as well as growing demand for biosimilars. North America led the market due to the growing use of biologics....
November 01, 2025
The single-cell biotherapeutics market is growing because single-cell technologies have accomplished significant achievements in diagnosing and treating different tumors, such as breast tumors, lung tumors, and gliomas....
November 01, 2025
The microfluidics in oncology market is growing due to this system offering more sensitive and precise detection of cancer biomarkers and therapeutic approaches than traditional assays....
November 01, 2025
The next-gen delivery system market is expanding due to growing innovations as well as rising diseases. North America led the market due to the growing use of biologics....
November 01, 2025
Based on market forecasts, the bacteriophage sector will expand from USD 55.35 million in 2024 to USD 124.09 million by 2034, experiencing a CAGR of 8.44%. The increasing incidence of antimicrobial resistance and the rising prevalence of infectious diseases bolster market growth. The availability of state-of-the-art research and development facilit...
November 01, 2025
According to forecasts, the Japan cell cancer vaccine market will grow from USD 320.6 million in 2024 to USD 576.4 million by 2034, with an expected CAGR of 6.04%. The Japan cell cancer vaccine market is expanding due to rising incidences of cancer as well as increasing use of peptide-based cancer vaccines....
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com